Page last updated: 2024-10-21

3-aminobenzamide and Pneumonia

3-aminobenzamide has been researched along with Pneumonia in 2 studies

Pneumonia: Infection of the lung often accompanied by inflammation.

Research Excerpts

ExcerptRelevanceReference
"In the second model, in blood of COPD-patients and healthy controls ex vivo pre-incubated with a physiological concentration of 1,7-dimethylxanthine (10microM), LPS-induced production of the cytokines IL-6 and TNF-alpha was significantly suppressed."1.36Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. ( Bast, A; Brauers, K; Geraets, L; Haegens, A; Hageman, GJ; Vernooy, JH; Weseler, AR; Wouters, EF, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Si, MK1
Mitaka, C1
Tulafu, M1
Abe, S1
Kitagawa, M1
Ikeda, S1
Eishi, Y1
Kurata, S1
Tomita, M1
Geraets, L1
Haegens, A1
Weseler, AR1
Brauers, K1
Vernooy, JH1
Wouters, EF1
Bast, A1
Hageman, GJ1

Other Studies

2 other studies available for 3-aminobenzamide and Pneumonia

ArticleYear
Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats.
    Respiratory research, 2013, Nov-15, Volume: 14

    Topics: Animals; Benzamides; Creatinine; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Kidney; Lacta

2013
Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
    European journal of pharmacology, 2010, Mar-10, Volume: 629, Issue:1-3

    Topics: Administration, Oral; Aged; Animals; Anti-Inflammatory Agents; Benzamides; Case-Control Studies; Cyt

2010